Significant Accounting Policies - Schedule of Potential Shares Outstanding not Included in Computation of Diluted Net Loss Per Common Share (Details) - shares	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Securities that could potentially dilute basic earnings per share (in shares)	8,335,926	5,968,904
Shares issuable upon exercise of stock options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Securities that could potentially dilute basic earnings per share (in shares)	2,895,127	1,066,643
Non-vested shares under restricted stock grants
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Securities that could potentially dilute basic earnings per share (in shares)	0	25,000
Shares issuable upon exercise of warrants \| Debt Financing
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Securities that could potentially dilute basic earnings per share (in shares)	51,855	51,855
Shares issuable upon exercise of warrants \| Torii amendment
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Securities that could potentially dilute basic earnings per share (in shares)	50,000	50,000
Shares issuable upon exercise of Series A and B warrants pursuant to 2024 equity financing
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Securities that could potentially dilute basic earnings per share (in shares)	2,387,703	4,775,406
Shares issuable upon exercise of Series C warrants pursuant to the Private Placement
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Securities that could potentially dilute basic earnings per share (in shares)	2,951,241	0